TY - JOUR
T1 - Clinical validation of targeted next-generation sequencing for inherited disorders
AU - Yohe, Sophia
AU - Hauge, Adam
AU - Bunjer, Kari
AU - Kemmer, Teresa
AU - Bower, Matthew
AU - Schomaker, Matthew
AU - Onsongo, Getiria
AU - Wilson, Jon
AU - Erdmann, Jesse
AU - Zhou, Yi
AU - Deshpande, Archana
AU - Spears, Michael D.
AU - Beckman, Kenneth
AU - Silverstein, Kevin A T
AU - Thyagarajan, Bharat
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Context: Although next-generation sequencing (NGS) can revolutionize molecular diagnostics, several hurdles remain in the implementation of this technology in clinical laboratories. Objectives.-To validate and implement an NGS panel for genetic diagnosis of more than 100 inherited diseases, such as neurologic conditions, congenital hearing loss and eye disorders, developmental disorders, nonmalignant diseases treated by hematopoietic cell transplantation, familial cancers, connective tissue disorders, metabolic disorders, disorders of sexual development, and cardiac disorders. The diagnostic gene panels ranged from 1 to 54 genes with most of panels containing 10 genes or fewer. Design: We used a liquid hybridization-based, targetenrichment strategy to enrich 10 067 exons in 568 genes, followed by NGS with a HiSeq 2000 sequencing system (Illumina, San Diego, California). Results: We successfully sequenced 97.6% (9825 of 10 067) of the targeted exons to obtain a minimum coverage of 20× at all bases. We demonstrated 100% concordance in detecting 19 pathogenic single-nucleotide variations and 11 pathogenic insertion-deletion mutations ranging in size from 1 to 18 base pairs across 18 samples that were previously characterized by Sanger sequencing. Using 4 pairs of blinded, duplicate samples, we demonstrated a high degree of concordance (>99%) among the blinded, duplicate pairs. Conclusions: We have successfully demonstrated the feasibility of using the NGS platform to multiplex genetic tests for several rare diseases and the use of cloud computing for bioinformatics analysis as a relatively lowcost solution for implementing NGS in clinical laboratories.
AB - Context: Although next-generation sequencing (NGS) can revolutionize molecular diagnostics, several hurdles remain in the implementation of this technology in clinical laboratories. Objectives.-To validate and implement an NGS panel for genetic diagnosis of more than 100 inherited diseases, such as neurologic conditions, congenital hearing loss and eye disorders, developmental disorders, nonmalignant diseases treated by hematopoietic cell transplantation, familial cancers, connective tissue disorders, metabolic disorders, disorders of sexual development, and cardiac disorders. The diagnostic gene panels ranged from 1 to 54 genes with most of panels containing 10 genes or fewer. Design: We used a liquid hybridization-based, targetenrichment strategy to enrich 10 067 exons in 568 genes, followed by NGS with a HiSeq 2000 sequencing system (Illumina, San Diego, California). Results: We successfully sequenced 97.6% (9825 of 10 067) of the targeted exons to obtain a minimum coverage of 20× at all bases. We demonstrated 100% concordance in detecting 19 pathogenic single-nucleotide variations and 11 pathogenic insertion-deletion mutations ranging in size from 1 to 18 base pairs across 18 samples that were previously characterized by Sanger sequencing. Using 4 pairs of blinded, duplicate samples, we demonstrated a high degree of concordance (>99%) among the blinded, duplicate pairs. Conclusions: We have successfully demonstrated the feasibility of using the NGS platform to multiplex genetic tests for several rare diseases and the use of cloud computing for bioinformatics analysis as a relatively lowcost solution for implementing NGS in clinical laboratories.
UR - http://www.scopus.com/inward/record.url?scp=84921527869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921527869&partnerID=8YFLogxK
U2 - 10.5858/arpa.2013-0625-OA
DO - 10.5858/arpa.2013-0625-OA
M3 - Article
C2 - 25611102
AN - SCOPUS:84921527869
SN - 0003-9985
VL - 139
SP - 204
EP - 210
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
IS - 2
ER -